Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications
Non-Muscle Invasive Recurrence and Management During Surveillance in Patients with Muscle-Invasive Bladder Cancer Who Achieve Clinical Complete Response to Neoadjuvant Chemotherapy.
Journal: The Journal of urology
Published: August 26, 2026
A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) for the Treatment of Non-Muscle Invasive BCG Unresponsive Urothelial Carcinoma of the Bladder.
Journal: The Journal of urology
Published: July 17, 2026
Targeting human kallikrein 2 in prostate cancer.
Journal: Clinical advances in hematology & oncology : H&O
Published: June 12, 2026
Treatments on the Horizon for Men with Advanced Prostate Cancer.
Journal: The Urologic clinics of North America
Published: April 15, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 19, 2026
Association between medication burden and acute care use in older metastatic prostate cancer patients on androgen receptor signaling inhibitors.
Journal: Cancer
Published: September 05, 2025
Erratum: Diabetes and Acute Care Use Among Patients With Metastatic Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
Journal: JCO oncology practice
Published: September 03, 2025
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.
Journal: Prostate cancer and prostatic diseases
Published: August 12, 2025
Diabetes and Acute Care Use Among Patients With Metastatic Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
Journal: JCO oncology practice
Published: June 12, 2025
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2025
Novel Strategies and Therapeutic Advances for Bladder Cancer.
Journal: Cancers
Published: May 27, 2025
Last Updated: 09/26/2026